Clinical Trials in North Carolina

Showing 13061-13080 of 17,526 trials

Recruiting African American Fathers/ Sons

NCT02811848

The purpose of this study is to develop and pilot test recruitment methods for a future study of prevention of sexually transmitted infections (STI), including the human immunodeficiency virus (HIV), among Black adolescent boys through sexual health education by their fathers.

Sexually Transmitted DiseasesHIV

Duke University28 participantsStarted May 2016

Greensboro, North Carolina, United States

COMPLETEDPhase 338 miles

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

NCT02058160

Primary Objective: To demonstrate the superiority of the insulin glargine/lixisenatide fixed ratio combination (FRC) to insulin glargine in glycated hemoglobin (HbA1c) change from baseline to Week 30. Secondary Objective: To compare the overall efficacy and safety of insulin glargine/lixisenatide FRC to insulin glargine (with or without metformin) over a 30 week treatment period in participants with type 2 diabetes.

Type 2 Diabetes

Sanofi736 participantsStarted Jan 2014

Birmingham, Alabama, United States • Sun City, Arizona, United States • Tempe, Arizona, United States +233 more locations

Recruiting African American Fathers/ Sons

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Find Trials by Condition in North Carolina

REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Improving Diabetes Outcomes for Persons With Severe Mental Illness

Dose-Escalation Study of GSK2126458

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Ovarian Cancer Vaccine for Patients in Remission

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

BE Study of Naftifine HCL